A peptide of the N terminus of GRK5 attenuates pressure-overload hypertrophy and heart failure
- 30 March 2021
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 14 (676)
- https://doi.org/10.1126/scisignal.abb5968
Abstract
Aberrant changes in gene expression underlie the pathogenesis and progression of pressure-overload heart failure, leading to maladaptive cardiac hypertrophy, ventricular remodeling, and contractile dysfunction. Signaling through the G protein Gq triggers maladaptation and heart failure, in part through the activation of G protein–coupled receptor kinase 5 (GRK5). Hypertrophic stimuli induce the accumulation of GRK5 in the nuclei of cardiomyocytes, where it regulates pathological gene expression through multiple transcription factors including NFAT. The nuclear targeting of GRK5 is mediated by an amino-terminal (NT) domain that binds to calmodulin (CaM). Here, we sought to prevent GRK5-mediated pathology in pressure-overload maladaptation and heart failure by expressing in cardiomyocytes a peptide encoding the GRK5 NT (GRK5nt) that encompasses the CaM binding domain. In cultured cardiomyocytes, GRK5nt expression abrogated Gq-coupled receptor–mediated hypertrophy, including attenuation of pathological gene expression and the transcriptional activity of NFAT and NF-κB. We confirmed that GRK5nt bound to and blocked Ca2+-CaM from associating with endogenous GRK5, thereby preventing GRK5 nuclear accumulation after pressure overload. We generated mice that expressed GRKnt in a cardiac-specific fashion (TgGRK5nt mice), which exhibited reduced cardiac hypertrophy, ventricular dysfunction, pulmonary congestion, and cardiac fibrosis after chronic transverse aortic constriction. Together, our data support a role for GRK5nt as an inhibitor of pathological GRK5 signaling that prevents heart failure.Keywords
Funding Information
- National Institutes of Health (P01 HL091799)
- National Institutes of Health (P01 HL075443)
- NIH Clinical Center (P01 HL075443)
- NIH Clinical Center (P01 HL091799)
- American Heart Association (17PRE33661220)
- Animal Health Australia (17PRE33661220)
This publication has 49 references indexed in Scilit:
- Distinct Structural Features of G Protein-Coupled Receptor Kinase 5 (GRK5) Regulate Its Nuclear Localization and DNA-Binding AbilityPLOS ONE, 2013
- G Protein-coupled Receptor Kinase 5 Is Localized to Centrosomes and Regulates Cell Cycle ProgressionOnline Journal of Public Health Informatics, 2012
- Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signalingTrends in Biochemical Sciences, 2011
- Nuclear Effects of G-Protein Receptor Kinase 5 on Histone Deacetylase 5–Regulated Gene Transcription in Heart FailureCirculation: Heart Failure, 2011
- G Protein-Coupled Receptor Kinase 5 Phosphorylation of Hip Regulates Internalization of the Chemokine Receptor CXCR4Biochemistry, 2011
- G-protein-coupled Receptor Kinase 5 Phosphorylates p53 and Inhibits DNA Damage-induced ApoptosisOnline Journal of Public Health Informatics, 2010
- G-protein-coupled-receptor kinases mediate TNFα-induced NF-κB signalling via direct interaction with and phosphorylation of IκBαBiochemical Journal, 2009
- The G-protein-coupled receptor kinase 5 inhibits NFκB transcriptional activity by inducing nuclear accumulation of IκBαProceedings of the National Academy of Sciences of the United States of America, 2008
- Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytesProceedings of the National Academy of Sciences of the United States of America, 2008
- Ca2+/Calmodulin-dependent Protein KinasesCellular and Molecular Life Sciences, 2008